Apparently a number of MLSOs in cytopathology have been transferred to the
clinical scientist scale, at least in SE England, to help solve a quality
and recruitment problem of a very political nature. What hospital CEO in
the UK would dare cut costs and potentially risk another highly publicised
"trial by media" if mistakes are discovered in the service.
This has been done within my hospital and was kept quiet for months even
within our directorate. The person concerned here is very competent and
manages a first class cervical cytology service to this and other hospitals
when needed. However I am concerned that this has been done within
cytology (and kept hidden from the other pathology departments) whilst
there are so many trainees in clinical biochemistry who have to obtain both
high quality first degrees and post graduate qualifications usually to the
MRCPath level to get beyond point 17 on our salary scale whereas the
cytologists have been transfered at substantially higher levels.
Will it happen in other pathology disciplines ? What should I tell the
trainee biochemists ?
Paul Eldridge Phone 0181 333 3255
Clinical Biochemistry
Lewisham Hospital
London SE13 6LH
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
|